| Title | Lung Cancer International |
| Abbreviation | Lung Cancer Int. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pulmonary and Respiratory Medicine (Q1); Oncology (Q2) |
| h-index | 3 |
| Overall Rank/Ranking | 3236 |
| SCImago Journal Rank (SJR) | 1.216 |
| Impact Score | 0.00 |
| Publisher | Hindawi Limited |
| Country | Egypt |
| ISSN | 20903200, 20903197 |
| Best Quartile | Q1 |
| Coverage History | 2015-2017 |
Lung Cancer International is a journal covering the technologies/fields/categories related to Pulmonary and Respiratory Medicine (Q1); Oncology (Q2). It is published by Hindawi Limited. The overall rank of Lung Cancer International is 3236. According to SCImago Journal Rank (SJR), this journal is ranked 1.216. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 3. The best quartile for this journal is Q1.
The ISSN of Lung Cancer International journal is 20903200, 20903197. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Lung Cancer International is cited by a total of 6 articles during the last 3 years (Preceding 2020).
The Impact IF 2020 of Lung Cancer International is 0.00, which is computed in 2021 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2020 of Lung Cancer International is 0.00. If the same downward trend persists, Impact IF may fall in 2021 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2020 | 0.00 |
| 2019 | 3.00 |
| 2018 | 2.50 |
| 2017 | 1.00 |
| 2016 | 1.00 |
| 2015 | 0.00 |
Lung Cancer International has an h-index of 3. It means 3 articles of this journal have more than 3 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Lung Cancer International is 20903200, 20903197. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Lung Cancer International is 3236. According to SCImago Journal Rank (SJR), this journal is ranked 1.216. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2020 | 1.216 |
| 2019 | 1.457 |
| 2018 | 0.353 |
| 2017 | 0.451 |
| 2016 | 0.123 |
| 2015 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2020 | 3236 |
| 2019 | 2350 |
| 2018 | 12345 |
| 2017 | 9993 |
| 2016 | 24735 |
| 2015 | 33141 |
Lung Cancer International is published by Hindawi Limited. It's publishing house is located in Egypt. Coverage history of this journal is as following: 2015-2017. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Lung Cancer International is Lung Cancer Int.. This abbreviation ('Lung Cancer Int.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pulmonary and Respiratory Medicine (Q1); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Lung Cancer International latest impact IF is 0.00. It's evaluated in the year 2020. The highest and the lowest impact IF or impact score of this journal are 3.00 (2019) and 0.00 (2020), respectively, in the last 6 years. Moreover, its average IS is 1.25 in the previous 6 years.
The Lung Cancer International has an SJR (SCImago Journal Rank) of 1.216, according to the latest data. It is computed in the year 2021. In the past 6 years, this journal has recorded a range of SJR, with the highest being 1.457 in 2019 and the lowest being in 2015. Furthermore, the average SJR of the Lung Cancer International over the previous 6-year period stands at 1.25.
The latest h-index of the Lung Cancer International is 3.
The Lung Cancer International is published by the Hindawi Limited, with its country of publication being the Egypt.
The Lung Cancer International is currently ranked 3236 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 6 years, this journal has experienced varying rankings, reaching its highest position of 2350 in 2019 and its lowest position of 33141 in 2015.
The standard ISO4 abbreviation for the Lung Cancer International is Lung Cancer Int..
Lung Cancer International is classified as a journal that the Hindawi Limited publishes.
The Lung Cancer International encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Lung Cancer International is assigned the following International Standard Serial Numbers (ISSN): 20903200, 20903197.
The best quartile for the Lung Cancer International is Q1 (2020).
The Lung Cancer International coverage history can be summarized as follows: 2015-2017.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| International Journal of Mathematical Education in Science and Technology | journal | 10040 | Taylor and Francis Ltd. | 39 | 1.33 |
| British Journal of Special Education | journal | 12024 | Wiley-Blackwell Publishing Ltd | 42 | 1.24 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
| European Surgery - Acta Chirurgica Austriaca | journal | 16873 | Springer Medizin | 23 | 0.58 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| Journal of Sociology | journal | 6009 | SAGE Publications Ltd | 58 | 3.21 |
| European Journal of Cancer, Supplement | journal | 9063 | Elsevier Ltd. | 28 | 1.93 |
| Year | Impact Score (IS) |
|---|---|
| 2021/2022 | Coming Soon |
| 2020 | 0.00 |
| 2019 | 3.00 |
| 2018 | 2.50 |
| 2017 | 1.00 |
| 2016 | 1.00 |
| 2015 | 0.00 |
